Back to Search
THERESA KURTZ, MD
MD
Obstetrics & Gynecology Physician
NPI: 1376048207IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
11410970-1205(UT)
CMS Specialties
PrimaryOBSTETRICS/GYNECOLOGY
Education
UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE
Class of 2018
Research & Publications (20)
Dissection of chromosome 18 blood pressure and salt-sensitivity quantitative trait loci in the spontaneously hypertensive rat.
PMID 19620519·Hypertension·2009
7-preclinical
Telmisartan increases fatty acid oxidation in skeletal muscle through a peroxisome proliferator-activated receptor-gamma dependent pathway.
PMID 18475159·J Hypertens·2008
4-observational
Long-term pioglitazone treatment enhances lipolysis in rat adipose tissue.
PMID 18936763·Int J Obes (Lond)·2008
7-preclinical
Identification of mutated Srebf1 as a QTL influencing risk for hepatic steatosis in the spontaneously hypertensive rat.
PMID 18071061·Hypertension·2008
7-preclinical
Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass.
PMID 18443592·Nat Genet·2008
7-preclinical
Identification of renal Cd36 as a determinant of blood pressure and risk for hypertension.
PMID 18587397·Nat Genet·2008
7-preclinical
Inhibition of cardiovascular cell proliferation by angiotensin receptor blockers: are all molecules the same?
PMID 18398340·J Hypertens·2008
7-preclinical
Beyond the classic angiotensin-receptor-blocker profile.
PMID 18580862·Nat Clin Pract Cardiovasc Med·2008
6-review
Molecule-specific effects of angiotensin II-receptor blockers independent of the renin-angiotensin system.
PMID 18535538·Am J Hypertens·2008
6-review
Direct linkage of mitochondrial genome variation to risk factors for type 2 diabetes in conplastic strains.
PMID 17693571·Genome Res·2007
7-preclinical
Molecular genetics of experimental hypertension and the metabolic syndrome: from gene pathways to new therapies.
PMID 17339535·Hypertension·2007
6-review
New treatment strategies for patients with hypertension and insulin resistance.
PMID 16563944·Am J Med·2006
6-review
Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis.
PMID 16567593·Hypertension·2006
7-preclinical
Fat-specific transgenic expression of resistin in the spontaneously hypertensive rat impairs fatty acid re-esterification.
PMID 16432541·Int J Obes (Lond)·2006
7-preclinical
Design and synthesis of the first generation of dithiolane thiazolidinedione- and phenylacetic acid-based PPARgamma agonists.
PMID 16821769·J Med Chem·2006
7-preclinical
A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects.
PMID 16213066·Vaccine·2006
4-observational
A new transgenic rat model of hepatic steatosis and the metabolic syndrome.
PMID 15809359·Hypertension·2005
7-preclinical
Treating the metabolic syndrome: telmisartan as a peroxisome proliferator-activated receptor-gamma activator.
PMID 15868121·Acta Diabetol·2005
6-review
BP-1107 [{2-[4-(2,4-dioxo-thiazolidin-5-ylmethyl)-phenoxy]-ethyl}-methyl-amide]: a novel synthetic thiazolidinedione that inhibits epidermal hyperplasia in psoriatic skin-severe-combined immunodeficient mouse transplants after topical application.
PMID 16109743·J Pharmacol Exp Ther·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 30 N 1900 E RM 2B200
SALT LAKE CITY, UT 84132 - Phone
- (801) 581-5501
Quick Facts
- NPI
- 1376048207
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 8
- Publications
- 20
Are you this provider?
Claim Your Profile